Evidence map›Paper›PMID 42338808›Full record

ArticleAmerican journal of ophthalmology case reports2026

Primary intraosseous cavernous hemangioma of the zygomatic bone.

Katerina Tori, Nicholas Levergood, Fernando Pellerano, Richard A Burgett, Ronald Martin

Abstract readCase Reports
In one paragraph

Article in American journal of ophthalmology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Katerina ToriDepartment of Ophthalmology, Indiana University School of Medicine, Indianapolis, IN, USA.
Nicholas LevergoodDepartment of Ophthalmology, Indiana University School of Medicine, Indianapolis, IN, USA.
Fernando PelleranoDepartment of Ophthalmology, Indiana University School of Medicine, Indianapolis, IN, USA.
Richard A BurgettDepartment of Oculoplastic and Orbital Surgery, Midwest Eye Institute, Carmel, IN, USA.
Ronald MartinDepartment of Oculoplastic and Orbital Surgery, Midwest Eye Institute, Carmel, IN, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: We present an uncommon case of primary intraosseous cavernous hemangioma involving the zygoma which displayed CD31 positivity on pathologic analysis. Observations: Macroscopic examination showed a bulging purple-red mass intrinsic to bone measuring 2.1 × 1.8 × 1.6 cm (Fig 2A). Histopathology demonstrated the lesion was comprised of thin-walled vascular channels lined by a monolayer of endothelial cells interspersed among bony trabeculae (Fig 2B) consistent with intraosseous cavernous hemangioma.7,8 Vascular walls lacked both venous and arterial features. Immunohistostaining demonstrated endothelial cells positive for CD31 (Fig 2C, black arrow), a histologic feature sensitive and specific for vascular endothelial cell differentiation.9 At three months follow up our patient had excellent cosmetic results, normal afferent visual function, and normal ocular motility without recurrence. Conclusions and importance: Primary intraosseous cavernous hemangioma of the zygoma is a rare benign orbital bone tumor that commonly presents as a painless mass causing facial asymmetry. Complete en bloc resection in this case with a modified Medpor implant yielded an excellent postoperative functional and aesthetic outcome. While hemangiomas are the most common orbital soft tissue neoplasm, it should additionally be considered in the differential diagnosis of bony tumors of the zygoma.

Indexed as

Cavernous hemangiomaMedporZygomatic pore

Identifiers

PMID42338808
PMCPMC13285629

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.